Delays in radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC) are associated with increased mortality risk, according to researchers at the University of Washington in Seattle.
Preview moderator Elizabeth M. Jaffee, MD, AACR president and deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, noted that clinical trials test new therapies in the healthiest of patients.
